# Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease

> **NCT03063190** · PHASE4 · WITHDRAWN · sponsor: **University of Sao Paulo General Hospital**

## Conditions studied

- Restless Leg Disorder
- Renal Disease Bone
- Renal Disease, End Stage
- Hyperparathyroidism, Secondary
- Adynamic Bone Disease
- Vitamin D Deficiency

## Interventions

- **DRUG:** Vitamin D
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03063190
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-31
- **Primary completion:** 2022-03-31
- **Final completion:** 2023-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** the main research is no longer in the Institution
- **Last updated:** 2021-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03063190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03063190, "Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03063190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*